Eli Lilly upgrades revenue and earnings per share expectations
A new 2021 prognosis for Eli Lilly's estimated revenue and earnings per share includes several upward adjustments.
.jpg)
by marketwire, translated by daniel pedersen
US-based pharmaceutical giant Eli Lilly has revised its revenue and earnings per share forecasts, it announces in a press release in connection with its investment community meeting.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
